GlassScriptPhysician profile
Alexis Furze
NPI 1447453048
$12,059.60
in general payments reported to CMS, 2019-2025
22 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,810 · 2020: $288 · 2021: $4,050 · 2022: $410 · 2023: $2,282 · 2024: $583 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,827 · Travel and Lodging: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,826.60 |
| Travel and Lodging | $675.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $3,679.98 | 2020-2021 | |
| Stryker Corporation | $1,745.39 | 2019-2025 | Xpress Loprofile, Clarifix Cryotherapy Device |
| Medical Device Business Services, INC. | $1,231.41 | 2019 | |
| Aerin Medical INC. | $1,192.03 | 2020-2025 | |
| Intersect Ent, INC. | $1,106.51 | 2019-2022 | |
| Optinose US, INC. | $1,027.54 | 2020-2025 | |
| Abbvie INC. | $634.12 | 2023-2025 | |
| Medtronic, INC. | $340.63 | 2023 | Propel |
| Glaxosmithkline, LLC. | $216.46 | 2021-2025 | Nucala |
| Trisalus Life Sciences, INC. | $197.91 | 2023 | Trinav Infusion System |
| Smith+Nephew, INC. | $163.55 | 2023-2025 | Halo, Coblation |
| Cook Medical LLC | $113.82 | 2019-2020 | |
| Neurent Medical Limited | $91.88 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Integra Lifesciences Corporation | $60.45 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Regeneron Healthcare Solutions, INC. | $57.36 | 2019-2024 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $54.41 | 2019-2021 | |
| Genzyme Corporation | $44.50 | 2022-2023 | |
| Karl Storz Endoscopy-America | $26.46 | 2025 | N.A. |
| Olympus America INC. | $22.95 | 2019 | |
| Abbott Laboratories | $18.85 | 2024 | Proclaim |
| Medtronic USA, INC. | $16.99 | 2019 | |
| Silk Road Medical, INC. | $16.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Furze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.